Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors

Hironobu Minami, Kenji Kawada, Hiromichi Ebi, Koichi Kitagawa, Yon Il Kim, Kazuhiro Araki, Hirofumi Mukai, Makoto Tahara, Hikaru Nakajima, Keiko Nakajima

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読